HAMAD MEDICAL CORPORATION
🇶🇦Qatar
Anticoagulation in Patients Suffering From COVID-19 Disease The ANTI-CO Trial
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2020-06-24
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT04445935
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 500
- Registration Number
- NCT04437693
Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf
- Conditions
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2020-06-26
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 100
- Registration Number
- NCT04430374
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Unlisted (UL), Qatar
Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2022-08-16
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 400
- Registration Number
- NCT04425382
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Flow Controlled Ventilation in ARDS Associated With COVID-19
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2020-05-22
- Last Posted Date
- 2020-06-25
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT04399317
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-04-16
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 456
- Registration Number
- NCT04349592
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke.
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-04-02
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 42
- Registration Number
- NCT04330872
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Economic Evaluation of Vancomycin Therapeutic Drug Monitoring Methods
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 65
- Registration Number
- NCT04297176
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
Synergistic Effect Of Parenteral Diclofenac And Paracetamol In The Pain Management Of Acute Limb Injuries
- First Posted Date
- 2019-12-16
- Last Posted Date
- 2023-03-01
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 162
- Registration Number
- NCT04199572
- Locations
- 🇶🇦
Hamad Medical Corporation, Doha, Qatar
An Evaluation Study to Identify the Effectiveness of Clinical Supervision With Regards to Work-related Strain, Sense of Coherence, Increased Cultural Sensitivity and the Impact on Patient's Care: A Prospective Longitudinal Study in Mental Health Services in Qatar
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2019-12-12
- Last Posted Date
- 2022-03-29
- Lead Sponsor
- Hamad Medical Corporation
- Target Recruit Count
- 136
- Registration Number
- NCT04196751
- Locations
- 🇶🇦
Mental Health Services, Hamad Medical Corporation, Doha, Qatar
© Copyright 2024. All Rights Reserved by MedPath